Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Thirty-day mortality rates after immunotherapy initiation.
Sütcüoğlu O, İlhan A, Tacar SY, Güven DC, Uçar G, Karadurmuş N, Yıldız F, Eraslan E, Uncu D, Tural D, Üner A, Günel N, Özdemir N, Kılıçkap S, Öksüzoğlu ÖB, Özet A, Yazıcı O. Sütcüoğlu O, et al. Among authors: tural d. Immunotherapy. 2021 Dec;13(17):1419-1426. doi: 10.2217/imt-2021-0082. Epub 2021 Oct 22. Immunotherapy. 2021. PMID: 34676791
Mortality in prostate cancer and use of statins.
Tural D, Yuce D, Kilickap S. Tural D, et al. J Clin Oncol. 2014 Jul 20;32(21):2274. doi: 10.1200/JCO.2013.54.3264. Epub 2014 Jun 9. J Clin Oncol. 2014. PMID: 24912890 No abstract available.
P95 HER2 fragments and breast cancer outcome.
Tural D, Akar E, Mutlu H, Kilickap S. Tural D, et al. Expert Rev Anticancer Ther. 2014 Sep;14(9):1089-96. doi: 10.1586/14737140.2014.929946. Epub 2014 Jun 26. Expert Rev Anticancer Ther. 2014. PMID: 24968823 Review.
Mortality in colorectal cancer and use of statins.
Tural D, Kilickap S. Tural D, et al. J Clin Oncol. 2015 Mar 1;33(7):810. doi: 10.1200/JCO.2014.58.7592. Epub 2015 Jan 20. J Clin Oncol. 2015. PMID: 25605846 No abstract available.
Prognostic factors for survival in metastatic renal cell carcinoma patients with brain metastases receiving targeted therapy.
Yildiz I, Bilici A, Karadurmuş N, Ozer L, Tural D, Kaplan MA, Akman T, Bayoglu IV, Uysal M, Yildiz Y, Tanriverdi Ö, Yazici O, Sürmeli Z, Serdar Turhal N, Bavbek S, Selçukbiricik F, Koca D, Basaran M. Yildiz I, et al. Among authors: tural d. Tumori. 2018 Dec;104(6):444-450. doi: 10.5301/tj.5000635. Epub 2018 May 9. Tumori. 2018. PMID: 28731496
149 results